fostamatinib disodium

fostamatinib disodium
Trade Name
Orphan Indication Immune thrombocytopenic purpura
USA Market Approval USA
USA Designation Date 2015-08-25 00:00:00
Sponsor Rigel Pharmaceuticals, Inc.;1180 Veterans Boulevard;South San Francisco, California, 94080